PHVS
PHARVARIS (PHVS)
NASDAQ
$33.20+$0.20 (+0.61%)
Price as of Jun 23, 2026 4:10 PM EDT
  • $1.8B
    Market Cap
  • 89.44%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-124.5M
+26.29%
-98.6M
+50.31%
-65.6M
+14.29%
-57.4M
+60.32%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
45.3M
-3.78%
47.1M
+50.37%
31.3M
+6.82%
29.3M
+59.89%
Operating Profit
-173.7M
+31.21%
-132.4M
+32.63%
-99.8M
+31.95%
-75.7M
+77.34%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-16,105
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
+100.00%
-16,105
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
16,105
N/A
Income before Taxes
-175.7M
+30.90%
-134.2M
+33.06%
-100.9M
+32.15%
-76.3M
+78.64%
Income Taxes
2.0M
+8.92%
1.8M
+74.01%
1.0M
+54.44%
679,087
+868.51%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-175.7M
+30.90%
-134.2M
+33.06%
-100.9M
+32.15%
-76.3M
+78.64%
Net Income from Continuing Operations Applicable to Common
-175.7M
+30.90%
-134.2M
+33.06%
-100.9M
+32.15%
-76.3M
+78.64%
Basic EPS and Net Income
-2.97
+19.76%
-2.48
-5.70%
-2.63
N/A
N/A
N/A
Diluted EPS and Net Income
-2.97
+19.76%
-2.48
-5.70%
-2.63
N/A
N/A
N/A
Basic Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Diluted Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
291.7M
+3.90%
280.7M
-28.25%
391.2M
+141.74%
161.8M
-22.70%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
291.7M
+3.90%
280.7M
-28.25%
391.2M
+141.74%
161.8M
-22.70%
Total Current Assets
291.7M
N/A
0
-100.00%
620,815
+6.56%
582,589
+10,122.65%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
642,470
-3.68%
667,000
+198.20%
223,678
+15.61%
193,474
+78.98%
Total Long-Term Assets
N/A
N/A
0
-100.00%
620,815
+6.56%
582,589
+10,122.65%
Total Assets
301.5M
+3.46%
291.4M
-26.92%
398.7M
+137.70%
167.7M
-20.91%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
30.2M
+27.81%
23.6M
+61.23%
14.6M
-20.72%
18.5M
+158.85%
Retained Earnings
-579.6M
+44.09%
-402.3M
+51.27%
-265.9M
+61.96%
-164.2M
+87.50%
Total Stockholders Equity
271.3M
+1.31%
267.8M
-30.28%
384.0M
+157.30%
149.3M
-27.17%
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-137.1M
+14.10%
-120.1M
+29.10%
-93.0M
+38.54%
-67.2M
+50.59%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-164,619
-69.41%
-538,086
+497.98%
-89,984
-27.61%
-124,296
-4.41%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
160.6M
+5,900.52%
2.7M
-99.18%
325.4M
+3,661.61%
8.7M
-93.98%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-59.27%
+52.37%
-38.90%
+9.22%
-35.62%
-11.38%
-40.19%
+47.30%
Return on Equity
-65.19%
+58.29%
-41.18%
+8.87%
-37.83%
-12.23%
-43.10%
+51.67%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow